// App-Quantinova.ai

: Increased Risk of Thrombosis in Antiphospholipid Syndrome Patients Treated with Direct Oral Anticoagulants. Results from an International Patient‐level Data Meta‐analysis

Researchers

Presenter

  • V. Dufrost

Principal Investigators

  • T. Reshetnyak

  • M. Satybaldyeva

  • Y. Du

  • X.-X. Yan

  • S. Salta

  • G. Gerotziafas

  • Z.-C. Jing

  • I. Elalamy

  • S. Zuily

  • D. Wahl

Medical Centers

  • CHU de Nancy, Vascular Medicine Division and Regional Competence Center For Rare Vascular And Systemic Autoimmune Diseases, Nancy, F-, France

  • V.A. Nasonova Research Institute of Rheumatology, Laboratory of Vascular Rheumatology, Moscow, Russian Federation

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Key Laboratory of Pulmonary Vascular Medicine, State Key Laboratory of Cardiovascular Disease, Beijing, China

  • Hôpital Tenon, Hôpitaux Universitaires Est Parisien, Assistance Publique Hôpitaux de Paris (AP‐HP), Service d'Hématologie Biologique, Paris, France

Locations

  • France

  • Russia

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved